Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration

American Journal of Health-System Pharmacy

Volumn 54, Issue 15, 1997, Pages 1735-1741

  Trissel, Lawrence A ^a   Martinez, Juan F ^a   Gilbert Jr , Doward L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Additives; Anti infective agents; Cefoperazone sodium; Cephalosporins; Cisatracurium besylate; Concentration; Dextrose; Incompatibilities; Injections; Skeletal muscle relaxants; Sodium chloride; Stability; Storage

Indexed keywords

ANTIINFECTIVE AGENT; ATRACURIUM BESILATE; CEFOPERAZONE; CEPHALOSPORIN DERIVATIVE; DRUG ADDITIVE; GLUCOSE; SODIUM CHLORIDE;

ARTICLE; DRUG INCOMPATIBILITY; DRUG STABILITY; DRUG STORAGE; INJECTION; PARTICLE SIZE; PRIORITY JOURNAL; SIMULATION; TURBIDITY;

EID: 0030857201     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/54.15.1735     Document Type: Article

References (6)

1. Nimbex package insert. Research Triangle Park, NC: Glaxo Wellcome Inc; 1995 Dec.
2. Trissel LA. Handbook on injectable drugs, 9th ed. Bethesda, MD: American Society of Health-System Pharmacists; 1996.
3. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
4. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm. 1993; 50:2359-63.
5. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm. 1992; 49:1716-9.
6. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm. 1993; 50:300-4.